Alexander ET - Search Results

1

Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.

Alexander ET, Towery JA, Miller AN, Kramer C, Hogan KR, Squires JE, Stuart RK, Costa LJ. Alexander ET, et al. Transfusion. 2011 Sep;51(9):1995-2000. doi: 10.1111/j.1537-2995.2011.03085.x. Epub 2011 Mar 10. Transfusion. 2011. PMID: 21392017

2

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.

Costa LJ, Alexander ET, Hogan KR, Schaub C, Fouts TV, Stuart RK. Costa LJ, et al. Among authors: alexander et. Bone Marrow Transplant. 2011 Jan;46(1):64-9. doi: 10.1038/bmt.2010.78. Epub 2010 Apr 12. Bone Marrow Transplant. 2011. PMID: 20383210

3

Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.

Costa LJ, Miller AN, Alexander ET, Hogan KR, Shabbir M, Schaub C, Stuart RK. Costa LJ, et al. Among authors: alexander et. Bone Marrow Transplant. 2011 Apr;46(4):523-8. doi: 10.1038/bmt.2010.170. Epub 2010 Jul 12. Bone Marrow Transplant. 2011. PMID: 20622909

4

Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice.

Alexander ET, Fahey E, Phanstiel O 4th, Gilmour SK. Alexander ET, et al. Biomedicines. 2023 Oct 5;11(10):2703. doi: 10.3390/biomedicines11102703. Biomedicines. 2023. PMID: 37893077 Free PMC article.

5

Immunomodulatory role of thrombin in cancer progression.

Alexander ET, Gilmour SK. Alexander ET, et al. Mol Carcinog. 2022 Jun;61(6):527-536. doi: 10.1002/mc.23398. Epub 2022 Mar 26. Mol Carcinog. 2022. PMID: 35338515

6

Harnessing the polyamine transport system to treat BRAF inhibitor-resistant melanoma.

Alexander ET, El Naggar O, Fahey E, Mariner K, Donnelly J, Wolfgang K, Phanstiel O, Gilmour SK. Alexander ET, et al. Cancer Biol Ther. 2021 Mar 4;22(3):225-237. doi: 10.1080/15384047.2021.1883185. Epub 2021 Feb 18. Cancer Biol Ther. 2021. PMID: 33602034 Free PMC article.

7

Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.

Alexander ET, Mariner K, Donnelly J, Phanstiel O 4th, Gilmour SK. Alexander ET, et al. Mol Cancer Ther. 2020 Oct;19(10):2012-2022. doi: 10.1158/1535-7163.MCT-19-1116. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747421 Free PMC article.

8

Polyamine-stimulation of arsenic-transformed keratinocytes.

Alexander ET, Mariner K, Borodyanskaya Y, Minton A, Gilmour SK. Alexander ET, et al. Carcinogenesis. 2019 Aug 22;40(8):1042-1051. doi: 10.1093/carcin/bgz115. Carcinogenesis. 2019. PMID: 31190067 Free PMC article.

9

A novel polyamine blockade therapy activates an anti-tumor immune response.

Alexander ET, Minton A, Peters MC, Phanstiel O 4th, Gilmour SK. Alexander ET, et al. Oncotarget. 2017 Aug 24;8(48):84140-84152. doi: 10.18632/oncotarget.20493. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137411 Free PMC article.

10

Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.

Alexander ET, Minton AR, Peters MC, van Ryn J, Gilmour SK. Alexander ET, et al. Oncotarget. 2016 Dec 20;7(51):85291-85305. doi: 10.18632/oncotarget.13300. Oncotarget. 2016. PMID: 27852034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters